Skin Cancer

Unparalleled expertise in skin cancer diagnosis and treatment.

The treatment of skin cancers such as melanoma has changed dramatically in recently years, with the advent of breakthrough therapies that harness the ability of the immune system to find and destroy cancer cells. The skin cancer experts at John Theurer Cancer Center—part of Hackensack University Medical Center in New Jersey—have been leaders in the development of every immunotherapy drug in use for melanoma today. No matter what kind of skin cancer you have, when you come to us for your care, you benefit from a multidisciplinary team of specialists with unparalleled expertise in skin cancer diagnosis and treatment. Our goal is to cure your cancer with attention to your cosmetic appearance, function, and quality of life. We don’t just care for you, but about you. In fact, according to Press-Ganey surveys, 99 percent of our patients report satisfaction with their care.

Comprehensive Skin Cancer Care

We treat every type and stage of skin cancer, from those in their earliest stages to metastatic disease, including:

  • Melanoma
  • Squamous cell carcinoma
  • Merkel cell carcinoma
  • Cutaneous sarcomas such as dermatofibrosarcoma and superficial leiomyosarcoma

Our dermatopathologists are highly skilled in diagnosing your skin lesion. An accurate diagnosis is the first step in choosing the most effective therapy for your skin cancer.


Excellence in Skin Cancer Surgery

The first skin cancer therapy is typically surgery to remove the lesion. Our dermatologic surgeons perform skin examination, skin biopsies, and removal of small and superficial cancers, as well as surgeries for more complex skin cancers. Our team includes a dermatologic surgeon trained in Mohs surgery—a precise approach to skin cancer surgery which may help preserve tissue and function. Skin cancer tissue is removed one layer at a time and analyzed for cancer cells. Once a layer is found that no longer contains cancer cells, the surgery is complete, sparing you from removal of additional skin.


Specialized Care for Skin Cancers after Transplant

People who receive a transplant are at risk for squamous cell carcinoma, due to the immunosuppressive drugs they take to prevent organ rejection. Hackensack University Medical Center has a renowned organ transplant program. As a result, our skin cancer experts see a high volume of transplant recipients, who need lifelong follow-up through regular skin screenings and education about protecting themselves from the sun’s harmful ultraviolet rays. Those patients who do develop squamous cell skin cancers often have aggressive disease that requires chemotherapy. As a result of treating these patients, our skin cancer specialists have amassed a great deal of experience treating all patients with squamous cell carcinoma of the skin.

Our Skin Cancer Specialists

Every Skin Cancer Specialist You Need

Your multidisciplinary care team includes dermatologists with extraordinary expertise in skin cancer surgery, including Mohs surgery and complex skin cancer operations; medical oncologists who use the latest anticancer drugs for skin cancer, based on the most recent research findings; a dermatopathologist, who has specialty training in skin cancer diagnosis; radiation oncologists; reconstructive surgeons; and clinical researchers evaluating promising new treatments. Through seamless integration, they collaborate and combine their knowledge, experience, and innovative thinking to design a plan of care that meets your individual needs. The care we provide is very personalized, enabling you to reach your doctor easily when you have questions or concerns.

A Precision Approach to Skin Cancer Treatment

We test each patient’s skin cancer to identify genetic mutations and learn about the molecular signals involved in skin cancer growth. We use the results of these tests to match you with targeted therapies. This “precision medicine” approach ensures that you receive the therapy that is best suited for the biology of your cancer.

A Robust Portfolio of Clinical Trials

While patients with advanced skin cancer are living longer due to the development of immunotherapies, many still succumb to metastatic disease. To improve patient outcomes, our investigators continue to conduct clinical trials of promising new therapies and treatment combinations in the hopes of extending lives and ultimately curing skin cancer. At John Theurer Cancer Center, you have access to clinical trials of new anticancer drugs, novel immunotherapies, and innovative treatment combinations—including early-phase trials through our dedicated Phase I Clinical Trials program (the first stage of testing in patients).